ETF Home ETF List Shorted Stocks Home About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for FHTX

Stock NameFoghorn Therapeutics Inc
TickerFHTX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS3441741077

Show aggregate FHTX holdings

News associated with FHTX

Foghorn Therapeutics (NASDAQ:FHTX) Coverage Initiated by Analysts at B. Riley
B. Riley began coverage on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a report released on Wednesday. The firm issued a buy rating and a $10.00 price objective on the stock. Foghorn Therapeutics Price Performance Shares of FHTX stock opened at $4.80 on Wednesday. The company’s fifty day simple moving average is $5.40 […] - 2025-09-18 04:26:54
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Given Average Rating of “Buy” by Analysts
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) has received a consensus recommendation of “Buy” from the eight brokerages that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating, five have given a buy rating and two have issued a strong buy rating on the company. […] - 2025-07-24 05:10:53
Foghorn Therapeutics (NASDAQ:FHTX) Stock Price Down 0.5% – What’s Next?
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) was down 0.5% during mid-day trading on Monday . The stock traded as low as $6.07 and last traded at $6.10. Approximately 68,552 shares traded hands during mid-day trading, a decline of 52% from the average daily volume of 143,521 shares. The stock had previously closed at […] - 2025-07-22 06:18:55
Analysts Set Foghorn Therapeutics Inc. (NASDAQ:FHTX) Target Price at $12.13
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned a consensus rating of “Buy” from the eight analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and two have given a strong buy […] - 2025-07-02 02:22:52
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives Consensus Recommendation of “Buy” from Analysts
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned an average rating of “Buy” from the eight research firms that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock with a hold rating, five have given a buy rating and two have assigned a strong buy […] - 2025-06-04 04:52:46
Lazard Asset Management LLC Invests $49,000 in Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Lazard Asset Management LLC acquired a new position in shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 10,582 shares of the company’s stock, valued at approximately $49,000. A number of other institutional investors have […] - 2025-05-26 05:22:58
Foghorn Therapeutics (NASDAQ:FHTX) Earns “Buy” Rating from HC Wainwright
Foghorn Therapeutics (NASDAQ:FHTX – Get Free Report)‘s stock had its “buy” rating reissued by stock analysts at HC Wainwright in a research note issued to investors on Wednesday,Benzinga reports. They currently have a $13.00 price target on the stock. HC Wainwright’s price objective would indicate a potential upside of 212.50% from the company’s previous close. […] - 2025-05-02 04:20:53
Geode Capital Management LLC Increases Position in Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Geode Capital Management LLC grew its holdings in Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) by 0.8% during the fourth quarter, HoldingsChannel reports. The firm owned 682,863 shares of the company’s stock after acquiring an additional 5,477 shares during the period. Geode Capital Management LLC’s holdings in Foghorn Therapeutics were worth $3,224,000 at the end […] - 2025-04-29 05:08:54
Foghorn Therapeutics (NASDAQ:FHTX) Given “Buy” Rating at HC Wainwright
HC Wainwright reaffirmed their buy rating on shares of Foghorn Therapeutics (NASDAQ:FHTX – Free Report) in a research report sent to investors on Friday,Benzinga reports. They currently have a $13.00 price target on the stock. FHTX has been the topic of a number of other reports. Jefferies Financial Group decreased their price objective on Foghorn […] - 2025-03-10 03:45:14
Los Angeles Capital Management LLC Makes New $75,000 Investment in Foghorn Therapeutics Inc. (NASDAQ:FHTX)
Los Angeles Capital Management LLC purchased a new position in shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) during the fourth quarter, HoldingsChannel reports. The fund purchased 15,851 shares of the company’s stock, valued at approximately $75,000. Several other institutional investors have also added to or reduced their stakes in FHTX. China Universal Asset […] - 2025-03-06 08:58:59
Foghorn Therapeutics Inc. (NASDAQ:FHTX) Receives $13.17 Average Target Price from Analysts
Shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) have been assigned a consensus recommendation of “Buy” from the six research firms that are covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a hold rating, four have issued a buy rating and one has assigned a strong buy […] - 2025-02-27 04:09:06
11,788 Shares in Foghorn Therapeutics Inc. (NASDAQ:FHTX) Acquired by China Universal Asset Management Co. Ltd.
China Universal Asset Management Co. Ltd. acquired a new position in shares of Foghorn Therapeutics Inc. (NASDAQ:FHTX – Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 11,788 shares of the company’s stock, valued at approximately $56,000. A number of other hedge funds […] - 2025-02-04 06:53:06

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) FHTX holdings

DateNumber of FHTX Shares HeldBase Market Value of FHTX SharesLocal Market Value of FHTX SharesChange in FHTX Shares HeldChange in FHTX Base ValueCurrent Price per FHTX Share HeldPrevious Price per FHTX Share Held
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of FHTX by Blackrock for IE00BYXG2H39

Show aggregate share trades of FHTX

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-10-06BUY3184.5304.815 4.787USD 1,522 4.68
2025-10-03BUY7424.6404.830 4.811USD 3,570 4.68
2025-10-02BUY1064.5405.038 4.988USD 529 4.68
2025-09-30BUY2104.8905.030 5.016USD 1,053 4.68
2025-09-26BUY2124.8604.970 4.959USD 1,051 4.68
2025-09-25BUY2124.6904.960 4.933USD 1,046 4.68
2025-09-18BUY1065.1405.190 5.185USD 550 4.68
2025-09-17BUY3184.8005.055 5.029USD 1,599 4.67
2025-09-11SELL-1065.2805.410 5.397USD -572 4.66 Loss of -78 on sale
2025-09-10BUY2125.1505.560 5.519USD 1,170 4.66
2025-09-05SELL-1055.7705.780 5.779USD -607 4.64 Loss of -119 on sale
2025-08-29SELL-3185.0605.115 5.109USD -1,625 4.63 Loss of -152 on sale
2025-08-27BUY2105.4105.630 5.608USD 1,178 4.62
2025-08-26SELL-1055.5305.590 5.584USD -586 4.62 Loss of -101 on sale
2025-08-25BUY1065.2505.600 5.565USD 590 4.61
2025-08-20SELL-4205.2605.300 5.296USD -2,224 4.61 Loss of -289 on sale
2025-08-18BUY2085.1005.180 5.172USD 1,076 4.60
2025-08-08SELL-2084.5805.020 4.976USD -1,035 4.59 Loss of -80 on sale
2025-08-05BUY1035.0005.240 5.216USD 537 4.59
2025-08-01SELL-3094.9905.250 5.224USD -1,614 4.58 Loss of -199 on sale
2025-07-30BUY4085.4506.200 6.125USD 2,499 4.57
2025-07-17SELL-2066.1006.190 6.181USD -1,273 4.46 Loss of -355 on sale
2025-07-16BUY4,7125.8805.945 5.939USD 27,982 4.45
2025-07-11SELL-7285.4005.450 5.445USD -3,964 4.42 Loss of -747 on sale
2025-07-07BUY2734.7805.159 5.121USD 1,398 4.40
2025-07-02BUY5,0054.9505.100 5.085USD 25,450 4.38
2025-06-25BUY1804.9005.030 5.017USD 903 4.37
2025-06-11BUY1824.5804.800 4.778USD 870 4.34
2025-06-10BUY1824.6304.780 4.765USD 867 4.34
2025-06-04SELL-914.2004.340 4.326USD -394 4.34 Profit of 1 on sale
2025-04-23BUY914.6804.770 4.761USD 433 4.38
2025-04-10SELL-7283.2303.370 3.356USD -2,443 4.47 Profit of 812 on sale
2025-04-08SELL-913.2103.780 3.723USD -339 4.51 Profit of 71 on sale
2025-04-07SELL-913.6803.680 3.680USD -335 4.52 Profit of 76 on sale
2025-04-04SELL-4553.4403.780 3.746USD -1,704 4.54 Profit of 360 on sale
2025-04-01BUY3643.3753.700 3.668USD 1,335 4.57
2025-03-31SELL-2733.6503.750 3.740USD -1,021 4.59 Profit of 232 on sale
2025-03-14SELL-1,4564.4304.730 4.700USD -6,843 4.69 Loss of -8 on sale
2025-03-07SELL-1824.5204.800 4.772USD -869 4.72 Loss of -10 on sale
2025-03-04SELL-914.3904.520 4.507USD -410 4.73 Profit of 21 on sale
2025-02-25BUY1825.1005.350 5.325USD 969 4.73
2025-02-19SELL-915.8706.120 6.095USD -555 4.64 Loss of -132 on sale
2025-02-13BUY2736.1606.312 6.297USD 1,719 4.42
2025-02-12BUY915.5205.720 5.700USD 519 4.38
2025-02-11BUY3645.3705.490 5.478USD 1,994 4.34
2025-01-17BUY3644.3104.440 4.427USD 1,611 4.42
2025-01-16BUY3644.2004.460 4.434USD 1,614 4.45
2025-01-10SELL-1824.3004.913 4.852USD -883 4.63 Loss of -40 on sale
2025-01-08SELL-3644.6504.790 4.776USD -1,738 4.59 Loss of -68 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of FHTX

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-1920,59160037,28455.2%
2025-09-1820,818068,55830.4%
2025-09-1718,022051,61734.9%
2025-09-1610,113019,18952.7%
2025-09-1514,288031,26345.7%
2025-09-1225,233041,40860.9%
2025-09-1127,347072,69037.6%
2025-09-109,459060,99415.5%
2025-09-098,419042,37719.9%
2025-09-0824,205051,78546.7%
2025-09-0539,06140048,48880.6%
2025-09-049,5151,60011,40983.4%
2025-09-037,148022,98731.1%
2025-09-0228,957061,70146.9%
2025-08-2918,943035,49153.4%
2025-08-2811,4777140,08928.6%
2025-08-275,202012,75840.8%
2025-08-2630,045052,89156.8%
2025-08-2514,407037,26538.7%
2025-08-2210,280045,13122.8%
2025-08-2112,020029,02041.4%
2025-08-2023,635043,02054.9%
2025-08-1919,458045,32742.9%
2025-08-1817,491027,32264.0%
2025-08-157,39024918,10740.8%
2025-08-1411,497033,69034.1%
2025-08-1320,880046,84144.6%
2025-08-1226,844056,71347.3%
2025-08-1113,4821,83426,99849.9%
2025-08-089,918943,54722.8%
2025-08-0727,994059,46547.1%
2025-08-0628,074065,40942.9%
2025-08-0515,929045,23135.2%
2025-08-0419,820037,83952.4%
2025-08-0124,624061,75339.9%
2025-07-3133,075090,18436.7%
2025-07-3041,0221,34766,32461.9%
2025-07-2926,3011,97788,69529.7%
2025-07-2824,080047,36550.8%
2025-07-2519,340031,05162.3%
2025-07-2423,464040,75857.6%
2025-07-2329,588048,81460.6%
2025-07-2224,942045,20855.2%
2025-07-2120,515026,53477.3%
2025-07-1846,83345365,98271.0%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Copyright Market Footprint Ltd. Privacy Policy